High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.

High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo.

An increased prevalence of epilepsy has been reported in many onchocerciasis endemic areas. The objective of this study was to determine the prevalence of epilepsy in onchocerciasis endemic areas in the Democratic Republic of the Congo (DRC) and investigate whether a higher annual intake of Ivermect...

Full description

Bibliographic Details
Main Authors:	Bethany Levick, Anne Laudisoit, Floribert Tepage, Chellafe Ensoy-Musoro, Michel Mandro, Caroline Bonareri Osoro, Patrick Suykerbuyk, Jean Marie Kashama, Michel Komba, Alliance Tagoto, Dadi Falay, Michael Begon, Robert Colebunders
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-07-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC5529017?pdf=render

Similar Items

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
by: Evy Lenaerts, et al.
Published: (2018-08-01)

Onchocerca volvulus as a risk factor for developing epilepsy in onchocerciasis endemic regions in the Democratic Republic of Congo: a case control study
by: Michel Mandro, et al.
Published: (2018-10-01)

Prevalence of River Epilepsy in the Orientale Province in the Democratic Republic of the Congo.
by: Robert Colebunders, et al.
Published: (2016-05-01)

Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-07-01)

Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case–control study
by: Robert Colebunders, et al.
Published: (2016-08-01)

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo
by: Housseini Dolo, et al.
Published: (2018-12-01)

No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
by: An Hotterbeekx, et al.
Published: (2021-07-01)

Potential Parasitic Causes of Epilepsy in an Onchocerciasis Endemic Area in the Ituri Province, Democratic Republic of Congo
by: Melissa Krizia Vieri, et al.
Published: (2021-03-01)

High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: A mixed-method assessment
by: Deby Mukendi, et al.
Published: (2019-02-01)

No Evidence Known Viruses Play a Role in the Pathogenesis of Onchocerciasis-Associated Epilepsy. An Explorative Metagenomic Case-Control Study
by: Michael Roach, et al.
Published: (2021-06-01)

The efficacy of a brief intervention to reduce alcohol use in persons with HIV in South Africa, a randomized clinical trial.
by: Diana Huis In 't Veld, et al.
Published: (2019-01-01)

Report of the first international workshop on onchocerciasis-associated epilepsy
by: Robert Colebunders, et al.
Published: (2018-03-01)

Onchocerciasis Prevalence among Persons with Epilepsy in an Onchocerciasis Hypo-Endemic Area in the Democratic Republic of Congo: A Cross-Sectional Study
by: An Hotterbeekx, et al.
Published: (2021-03-01)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
by: Alfred Dusabimana, et al.
Published: (2020-10-01)

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
by: Michel Mandro, et al.
Published: (2020-03-01)

Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis<i>-</i>Associated Epilepsy
by: An Hotterbeekx, et al.
Published: (2020-03-01)

Onchocerciasis-associated epilepsy an unrecognised important preventable public health problem
by: R. Colebunders, et al.
Published: (2020-12-01)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-02-01)

Review of the National Program for Onchocerciasis Control in the Democratic Republic of the Congo
by: Jean-Claude Makenga Bof, et al.
Published: (2019-06-01)

Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study
by: Melissa Krizia Vieri, et al.
Published: (2021-06-01)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
by: Michel Mandro, et al.
Published: (2020-01-01)

Onchocerciasis in the Democratic Republic of Congo: Survey of knowledge, attitude and perception in Bandundu province
by: Jean-Claude Makenga Bof, et al.
Published: (2017-09-01)

Single versus multiple dose ivermectin regimen in onchocerciasis-infected persons with epilepsy: A randomized clinical trial
by: M. Mandro, et al.
Published: (2020-12-01)

Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study
by: Alfred Dusabimana, et al.
Published: (2020-07-01)

Onchocerciasis-associated epilepsy: another piece in the puzzle from the Mahenge mountains, southern Tanzania
by: Christoph Kaiser, et al.
Published: (2019-05-01)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
by: Charlotte Boullé, et al.
Published: (2019-03-01)

Study of onchocerciasis-related visual impairment in North Kivu province of the Democratic Republic of Congo in Africa
by: Vinod K Baranwal, et al.
Published: (2020-01-01)

Nodding Syndrome May Be Only the Ears of the Hippo.
by: Joseph Francis Wamala, et al.
Published: (2015-08-01)

Comparison of Diagnostic Tests for <i>Onchocerca volvulus </i>in the Democratic Republic of Congo
by: An Hotterbeekx, et al.
Published: (2020-06-01)

Validation of the rapid assessment procedure for loiasis (RAPLOA) in the democratic republic of Congo
by: Wanji Samuel, et al.
Published: (2012-02-01)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
by: Sarah O’Neill, et al.
Published: (2019-05-01)

High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin
by: Bruno P. Mmbando, et al.
Published: (2018-06-01)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-08-01)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
by: Robert Colebunders, et al.
Published: (2019-10-01)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
by: Nolbert Gumisiriza, et al.
Published: (2020-03-01)

Onchocerciasis: the beginning of the end?
by: Adrian Hopkins
Published: (2019-02-01)

Information for onchocerciasis control
by: Adrian Hopkins
Published: (2010-12-01)

Investing in Onchocerciasis Control: Financial Management of the African Programme for Onchocerciasis Control (APOC).
by: Donald A P Bundy, et al.
Published: (2015-05-01)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016-12-01)

Uptake of HIV/AIDS Services Following a Positive Self-Test Is Lower in Men Than Women in the Democratic Republic of the Congo
by: Serge Tonen-Wolyec, et al.
Published: (2021-07-01)